Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,579.34
(
1.28%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
99.79
(
3.10%
)
Bitcoin
70,474.00
(
-0.60%
)
News Focus
News Focus

Replies to post #137726 on Biotech Values

Replies to #137726 on Biotech Values
icon url

mcbio

02/23/12 7:55 PM

#137727 RE: DewDiligence #137726

Quiz answer: VRTX’s planned phase-2b trial is its first HCV trial in some time that does not have a response-guided protocol.

What's the rationale for not using a response-guided protocol?